NICE director Leo Apotheker reports option holdings

NICE Ltd. director Leo Apotheker filed an initial ownership report showing multiple stock option grants over Ordinary Shares.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

NICE Ltd. director Leo Apotheker filed an initial ownership report showing multiple stock option grants over Ordinary Shares. The options cover various underlying share amounts with exercise prices such as 224.1800 and 144.9030 and expiration dates from 2026 through 2031, with some already fully vested and others vesting through September 30, 2026.

Insider Trade Summary

12 transactions reported

Mixed 12 txns

Insider Apotheker Leo

Role Director

Type	Security	Shares	Price	Value
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--

Holdings After Transaction: Options — 18,915 contracts (Direct)

Footnotes (3)

F1. The stock option is fully vested and currently exercisable.
F2. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.
F3. The stock option will vest on September 30, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Leo Apotheker’s Form 3 filing for NICE Ltd. (NCSYF) show?

The Form 3 shows Leo Apotheker’s initial ownership in NICE Ltd. through multiple stock option grants on Ordinary Shares. It lists exercise prices, expiration dates, and vesting status, but reports no recent purchases or sales of shares.

What types of securities does Leo Apotheker hold in NICE Ltd. (NCSYF)?

Leo Apotheker holds stock options over NICE Ltd. Ordinary Shares. Each option line specifies an exercise price, such as 224.1800 or 144.9030, and an expiration date between 2026 and 2031, reflecting different option grants he has received.

Are Leo Apotheker’s NICE Ltd. options vested or still vesting?

Some options are fully vested and currently exercisable, while others vest over time. One grant tied to 746 Ordinary Shares is partly vested, with remaining portions vesting in three equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.

Do the reported NICE Ltd. (NCSYF) options for Leo Apotheker have specific expiration dates?

Yes, each option grant has a defined expiration date. The filing lists expirations ranging from September 10, 2026 through September 30, 2031, after which any unexercised options would no longer be available to convert into Ordinary Shares.

Does Leo Apotheker’s NICE Ltd. Form 3 indicate any recent stock trades?

The Form 3 does not indicate recent stock purchases or sales. It primarily records existing stock option holdings as of the reporting date, including their exercise prices, underlying Ordinary Shares, vesting status, and expiration schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/18/2026 - 09:12 AM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Apotheker Leo

(Last)

(First)

(Middle)

221 RIVER STREET

(Street)

HOBOKEN

NEW JERSEY

07030

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NICE Ltd. [ NICE ]

3a. Foreign Trading Symbol
[NICE.TA]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options	⁽¹⁾	09/10/2026	Ordinary Shares	2,785	$224.18	D
Options	⁽¹⁾	09/10/2026	Ordinary Shares	696	$0.2929	D
Options	⁽¹⁾	04/28/2027	Ordinary Shares	2,214	$232.2005	D
Options	⁽¹⁾	04/28/2027	Ordinary Shares	554	$0.3076	D
Options	⁽¹⁾	06/22/2028	Ordinary Shares	2,516	$197.4245	D
Options	⁽¹⁾	06/22/2028	Ordinary Shares	629	$0.2887	D
Options	⁽¹⁾	07/17/2029	Ordinary Shares	2,086	$206.5232	D
Options	⁽¹⁾	07/17/2029	Ordinary Shares	521	$0.2751	D
Options	⁽¹⁾	07/03/2030	Ordinary Shares	2,545	$168.4643	D
Options	⁽¹⁾	07/03/2030	Ordinary Shares	636	$0.2657	D
Options	⁽²⁾	09/30/2031	Ordinary Shares	2,987	$144.903	D
Options	⁽³⁾	09/30/2031	Ordinary Shares	746	$0.3025	D

Explanation of Responses:

1. The stock option is fully vested and currently exercisable.

2. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.

3. The stock option will vest on September 30, 2026.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Alon Levy, Attorney-in-Fact for Leo Apotheker	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR